Deep morphea

Area of Science:

• Dermatology
• Rheumatology
• Pathology

Background:

• Deep morphea comprises conditions with inflammation and sclerosis affecting deep dermis, panniculus, fascia, or muscle.
• Includes morphea profunda, eosinophilic fasciitis, and disabling pansclerotic morphea of children.
• Distinguishing these entities is difficult due to overlapping clinical and histological features.

Purpose of the Study:

• To review the clinical spectrum and diagnostic challenges of deep morphea.
• To highlight associated systemic findings and laboratory abnormalities.
• To discuss current, albeit nonstandardized, treatment approaches.

Main Methods:

• Review of literature on deep morphea and related conditions.
• Analysis of clinical presentations, histological findings, and diagnostic criteria.
• Synthesis of information on associated complications and treatment outcomes.

Main Results:

• Deep morphea conditions share similar inflammatory and sclerotic histological findings, differing mainly in depth.
• Clinical overlap makes precise classification challenging.
• Associated symptoms like arthralgias, contractures, and carpal tunnel syndrome are common.
• Visceral complications (pulmonary, esophageal, cardiac) are rare but reported.
• Laboratory findings may include eosinophilia, hypergammaglobulinemia, elevated ESR, and autoantibodies.

Conclusions:

• Deep morphea represents a spectrum of related disorders with overlapping characteristics.
• Accurate diagnosis requires integrating clinical, histological, and sometimes systemic findings.
• Treatment remains nonstandardized, with potential benefits from UVA irradiation, anti-inflammatory, and immunosuppressive agents.